https://scholars.lib.ntu.edu.tw/handle/123456789/633603
Title: | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | Authors: | WEI-WU CHEN Hsiao, Wen Dai, Ming-Shen CHING-HUNG LIN DWANG-YING CHANG I-CHUN CHEN MING-YANG WANG Chang, Shu-Han Huang, Shu-Min ANN-LII CHENG Wu, Ko-Wen Tan, Kien Thiam YEN-SHEN LU |
Keywords: | Breast cancer; Cell-free tumor DNA; Endocrine receptor; Liquid biopsy | Issue Date: | 21-Jun-2023 | Source: | Breast cancer research and treatment | Abstract: | How to factor both tumor burden and oncogenic genomic mutations as variables to predict the outcome of endocrine-based therapy (ET) in ER-positive/HER2-negative metastatic breast cancer patients (MBC) remains to be explored. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/633603 | ISSN: | 01676806 | DOI: | 10.1007/s10549-023-06967-3 |
Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.